ATE199570T1 - Selbst-replizierende episomale expressionsvektoren, welche gewebespezifische expression vermitteln - Google Patents

Selbst-replizierende episomale expressionsvektoren, welche gewebespezifische expression vermitteln

Info

Publication number
ATE199570T1
ATE199570T1 AT97937661T AT97937661T ATE199570T1 AT E199570 T1 ATE199570 T1 AT E199570T1 AT 97937661 T AT97937661 T AT 97937661T AT 97937661 T AT97937661 T AT 97937661T AT E199570 T1 ATE199570 T1 AT E199570T1
Authority
AT
Austria
Prior art keywords
self
expression
provide tissue
expression vectors
specific
Prior art date
Application number
AT97937661T
Other languages
English (en)
Inventor
Michael Antoniou
Franklin Geradus Grosveld
Original Assignee
Medical Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9617214.3A external-priority patent/GB9617214D0/en
Application filed by Medical Res Council filed Critical Medical Res Council
Application granted granted Critical
Publication of ATE199570T1 publication Critical patent/ATE199570T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16241—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/46—Vector systems having a special element relevant for transcription elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Ceramics (AREA)
  • Telephonic Communication Services (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97937661T 1996-08-16 1997-08-18 Selbst-replizierende episomale expressionsvektoren, welche gewebespezifische expression vermitteln ATE199570T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9617214.3A GB9617214D0 (en) 1996-08-16 1996-08-16 Vector
US2504096P 1996-08-28 1996-08-28
PCT/GB1997/002213 WO1998007876A2 (en) 1996-08-16 1997-08-18 Self-replicating episomal expression vectors conferring tissue-specific gene expression

Publications (1)

Publication Number Publication Date
ATE199570T1 true ATE199570T1 (de) 2001-03-15

Family

ID=26309883

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97937661T ATE199570T1 (de) 1996-08-16 1997-08-18 Selbst-replizierende episomale expressionsvektoren, welche gewebespezifische expression vermitteln

Country Status (11)

Country Link
EP (1) EP0918874B1 (de)
JP (1) JP2000516472A (de)
AT (1) ATE199570T1 (de)
AU (1) AU725474B2 (de)
CA (1) CA2263796A1 (de)
DE (1) DE69704206T2 (de)
DK (1) DK0918874T3 (de)
ES (1) ES2157084T3 (de)
GR (1) GR3035838T3 (de)
PT (1) PT918874E (de)
WO (1) WO1998007876A2 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1124499A (en) * 1997-10-28 1999-05-17 Maxygen, Inc. Human papillomavirus vectors
ES2375266T3 (es) 1998-07-21 2012-02-28 Millipore Corporation Un polinucleótido que comprende un elemento de apertura de cromatina ubicuo (ucoe).
WO2000005393A2 (en) 1998-07-21 2000-02-03 Cobra Therapeutics Limited A polynucleotide comprising a ubiquitous chromatin opening element (ucoe)
US6417002B1 (en) * 1999-02-11 2002-07-09 Pharmacopeia, Inc. Method for maintenance and selection of episomes
DE19942149A1 (de) * 1999-09-03 2001-03-15 Daniele Zink Verfahren zur Expression von exogenen Sequenzen in Säugerzellen
AU783128B2 (en) 2000-03-02 2005-09-29 Innovata Plc TCF responsive element
KR100996016B1 (ko) 2000-09-20 2010-11-22 밀리포어 코포레이션 폴리뉴클레오티드
WO2002081677A2 (en) 2001-04-05 2002-10-17 Ml Laboratories Plc Improved gene expression
US7812148B2 (en) 2001-04-05 2010-10-12 Millipore Corporation Vectors comprising CpG islands without position effect varigation and having increased expression
SI1390516T1 (sl) * 2001-05-03 2009-08-31 Fit Biotech Oy Novi ekspresijski vektorji in njihova uporaba
FI116851B (fi) 2001-05-03 2006-03-15 Fit Biotech Oyj Plc Ilmentämisvektori, sen käyttöjä ja menetelmä sen valmistamiseksi sekä sitä sisältäviä tuotteita
GB2384001B (en) 2001-12-14 2004-02-04 Asterion Ltd Chimeric growth hormone-growth hormone receptor proteins
WO2004031229A2 (en) 2002-10-07 2004-04-15 Ludwig Institute For Cancer Research P53 binding polypeptide
ATE471988T1 (de) 2003-02-01 2010-07-15 Millipore Corp Verbesserte genetische elemente für eine erhöhte genexpression
FI116068B (fi) 2003-09-15 2005-09-15 Fit Biotech Oyj Plc Uusi selektiojärjestelmä, siinä käyttökelpoinen vektori, bakteerisolukantoja sekä menetelmä solujen valikoimiseksi
GB0328690D0 (en) 2003-12-10 2004-01-14 Ludwig Inst Cancer Res Tumour suppressor protein
GB0406330D0 (en) * 2004-03-20 2004-04-21 Univ Sheffield Gene screen
GB0509965D0 (en) 2005-05-17 2005-06-22 Ml Lab Plc Improved expression elements
WO2008085962A2 (en) 2007-01-08 2008-07-17 Millipore Corporation Cell culture methods for producing recombinant proteins in the presence of reduced levels of one or more contaminants
ES2643610T3 (es) * 2010-05-19 2017-11-23 Icosagen Cell Factory Oü Método y kit para identificar compuestos capaces de inhibir la replicación del virus del papiloma humano
JP5863338B2 (ja) * 2011-08-25 2016-02-16 株式会社東芝 プラスミド型ベクター、遺伝子プロモーター活性の検出方法、及びアッセイキット
EP3137100B1 (de) 2014-04-15 2023-12-20 University Of Virginia Patent Foundation Isolierte t-zellenrezeptoren und verfahren zur verwendung davon
GB201710973D0 (en) 2017-07-07 2017-08-23 Avacta Life Sciences Ltd Scaffold proteins
WO2020018715A1 (en) 2018-07-17 2020-01-23 Massachusetts Institute Of Technology Soluble multimeric immunoglobulin-scaffold based fusion proteins and uses thereof
CA3120576A1 (en) 2018-11-26 2020-06-04 Massachusetts Institute Of Technology Compositions and methods for immune tolerance
WO2021074695A1 (en) 2019-10-16 2021-04-22 Avacta Life Sciences Limited PD-L1 INHIBITOR - TGFβ INHIBITOR BISPECIFIC DRUG MOIETIES.
GB202101299D0 (en) 2020-06-09 2021-03-17 Avacta Life Sciences Ltd Diagnostic polypetides and methods
WO2022043686A1 (en) 2020-08-25 2022-03-03 Thrombosis Research Institute Vaccine
GB2606693A (en) 2021-04-08 2022-11-23 Exosis Inc Fusion protein
WO2022234003A1 (en) 2021-05-07 2022-11-10 Avacta Life Sciences Limited Cd33 binding polypeptides with stefin a protein
GB202107057D0 (en) 2021-05-18 2021-06-30 Univ York Glycosylation method
TW202334196A (zh) 2021-10-07 2023-09-01 英商阿法克塔生命科學有限公司 Pd-l1結合多肽
WO2023057946A1 (en) 2021-10-07 2023-04-13 Avacta Life Sciences Limited Serum half-life extended pd-l1 binding polypeptides
WO2023153876A1 (ko) 2022-02-10 2023-08-17 주식회사 아피셀테라퓨틱스 Cd40l에 특이적으로 결합하는 스테핀 a 단백질 변이체 및 이의 용도
WO2023218243A1 (en) 2022-05-12 2023-11-16 Avacta Life Sciences Limited Lag-3/pd-l1 binding fusion proteins
GB202319661D0 (en) 2023-12-20 2024-01-31 Univ Southampton Antigen binding proteins

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5173414A (en) * 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
GB9027917D0 (en) * 1990-12-21 1991-02-13 Ici Plc Expression systems
US5631162A (en) * 1993-06-11 1997-05-20 Massachusetts Institute Of Technology Retroviral vectors for transducing β-globin gene and β-locus control region derivatives
WO1995032299A1 (en) * 1994-05-20 1995-11-30 The Board Of Trustees Of The Leland Stanford Junior University An autonomous replication system for mammalian cells
US6110666A (en) * 1994-06-09 2000-08-29 Medical Research Council Locus control subregions conferring integration-site independent transgene expression abstract of the disclosure
WO1996017072A2 (en) * 1994-11-30 1996-06-06 Chiron Viagene, Inc. Recombinant alphavirus vectors

Also Published As

Publication number Publication date
AU725474B2 (en) 2000-10-12
GR3035838T3 (en) 2001-08-31
DE69704206T2 (de) 2001-08-30
DE69704206D1 (de) 2001-04-12
DK0918874T3 (da) 2001-05-14
CA2263796A1 (en) 1998-02-26
WO1998007876A3 (en) 1998-04-16
EP0918874A2 (de) 1999-06-02
ES2157084T3 (es) 2001-08-01
EP0918874B1 (de) 2001-03-07
PT918874E (pt) 2001-08-30
WO1998007876A2 (en) 1998-02-26
AU4020997A (en) 1998-03-06
JP2000516472A (ja) 2000-12-12

Similar Documents

Publication Publication Date Title
DE69704206D1 (de) Selbst-replizierende episomale expressionsvektoren, welche gewebespezifische expression vermitteln
DE69736502D1 (de) Verstärkungsregler
DE69532970D1 (en) Sprühgetrocknetes erythropoietin
AU7826491A (en) Novel bacillus thuringiensis microbes active against nematodes, and genes encoding novel nematode-active toxins cloned from bacillus thuringiensis isolates
FI964308A0 (fi) Radioresurssien käyt¦n ohjausmenetelmä
NO983426L (no) FremgangsmÕte for styring av belastning, samt radiosystem
WO1996017072A3 (en) Recombinant alphavirus vectors
ZA977948B (en) Process for the control of weeds.
GB2317514B (en) Variable gain control
ZA976559B (en) Method for activation of bleaches.
AU1643197A (en) Variable-gain control
FI962693L (fi) Geeni-ilmentymisen kontrolli
AU6102698A (en) Call control method
EP1010761A4 (de) Gen
ZA962709B (en) Method of controlling harmful fungi.
GB9713145D0 (en) Gain control
HUP9902443A3 (en) New process for making phenyl substituted 2(5h)-furanones, intermediates
NO961863D0 (no) Preparater for nematodekontroll
ZA984509B (en) Method of controlling harmful fungi.
AU2744995A (en) Expression control polynucleotides derived from spliceosomal protein gene promoters
DE69723940D1 (de) Verstärkungsregler
ATE371032T1 (de) Methoden und materialien fur genexpression
GB9716654D0 (en) Servo metal control
AU674148C (en) Control of cellular infiltration
ZA97276B (en) Isolation of fibrinogen by affinity chromatography.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee